McKinsey & Company Launches CustomerOne to Help Marketers Unlock Growth

End-to-end personalization and customer value management offering drives a 10 to 20 percent revenue lift for organizations NEW YORK and LONDON, Nov. 12, 2021 (GLOBE NEWSWIRE) — McKinsey & Company today announced the launch of CustomerOne, a proven approach and comprehensive toolkit designed to help organizations accelerate personalization and customer value management. CustomerOne draws on […]

Read More

South African Qualification Authority and World Education Services Partner to Facilitate Qualifications Recognition for Refugees and Displaced People in South Africa

OTTAWA, Nov. 12, 2021 (GLOBE NEWSWIRE) — Last night, at the Groningen Declaration Network annual meeting, the South African Qualification Authority (SAQA) and World Education Services (WES) signed a partnership agreement that will ensure eligible refugees and displaced individuals can have their qualifications assessed and recognized in South Africa. A significant number of individuals seeking […]

Read More

Noteworthy Renal Research Progress Highlighted by George Clinical Scientific Leaders During ASN Kidney Week

OVERLAND PARK, KS., Nov. 12, 2021 (GLOBE NEWSWIRE) — New kidney and metabolic research involving George Clinical teams and scientific leaders has received global attention during the 2021 American Society of Nephrology’s Kidney Week including contributions featured as abstracts, poster sessions, publications and presentations. Despite the restrictions of a global pandemic, meaningful renal clinical research […]

Read More

Digihost to Commence Trading on Nasdaq on Monday, November 15

TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (TSXV: DGHI; OTCQB: HSSHD), an innovative North American-based Bitcoin self-mining company, today announced that the Company has been approved to list on the Nasdaq Capital Market (“Nasdaq”), and that trading on Nasdaq is expected to begin on Monday, November 15, 2021, […]

Read More

Philogen Provides Corporate Update

Philogen Provides Corporate Update Nidlegy™ and Fibromun are on track with planned timelines in pivotal clinical trials Fibromun shows potent activity in last-line glioblastoma in combination with Lomustine The OncoFAP platform shows promising results beyond radio-conjugates Cash & cash equivalents of €107.8M Philogen’s management team will hold a Webinar to discuss the news on November […]

Read More